Mini-Tumors grown in lab could predict breast cancer treatment response

NCT ID NCT05317221

Recruiting now Knowledge-focused Sponsor: Maastricht Radiation Oncology Source: ClinicalTrials.gov ↗

First seen May 15, 2026 · Last updated Jun 18, 2026 · Updated 7 times

Summary

This study aims to create a 'living biobank' of breast cancer organoids—tiny 3D tumor models grown from patient tissue. Researchers will test whether these organoids can predict how a patient's cancer will behave and respond to treatments. The goal is to develop better tools for personalized breast cancer care. The study will involve 60 women with breast cancer who are scheduled for surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Maastricht University Medical Center
RECRUITING

Maastricht, 6202 AZ, Netherlands

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER